WALTHAM, Mass. --(Business Wire)-- Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced its senior vice president and chief financial officer, Chris... [read full story]
|
RELATED
|
|
a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year agreement with Quotient Clinical, which specializes in early development services for a broad range of...
Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year agreement with Quotient Clinical, which specializes in read more
Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year agreement with Quotient Clinical, which specializes in early development services for a broad...
WALTHAM, Mass.----Phase Forward , a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year agreement with Quotient Clinical, which specializes in early development...
Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year agreement with Quotient Clinical, which specializes in early development services...
Specialist in Early Development Services Will Use InForm Product and Central Designer Module to Streamline Clinical Trial Delivery Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical...
WALTHAM, Mass. - Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year agreement with Quotient Clinical, which specializes in early...
WALTHAM, Mass.----Phase Forward Incorporated , a leading provider of data management solutions for clinical trials and drug safety, announced today that its board of directors has authorized the repurchase of up to $40.0...
Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, announced today that its board of directors has authorized the repurchase of up to $40.0 million of...
WALTHAM, Mass. - Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, announced today that its board of directors has authorized the repurchase of up to...
Ambulatory Health Care, Scientific Discoveries, Senior Management, General Management Issues, Health Care, CFO, Medical Research, GlaxoSmithKline, Eli Lilly, Novartis, PAREXEL, Boston Scientific, AstraZeneca, Procter & Gamble, Novo-Nordisk, Massachusetts, United States of America, North America, Waltham (Massachusetts)
